'We were heard': Father thanks Dubai Ruler for Dh7 million that saved child's life
At 9.05am, doctors along with the nurses walked in carrying a small, sealed red box that contains the life-saving gene therapy medicine and could change Yaqeen's future forever. Looking at it, Yaqeen's mother stood frozen as she saw the medicine being brought in.
Her eyes followed every movement. And then, she smiled, the kind of smile that only a mother who's lived through months of fear and sleepless nights could give. Her eyes rose up, but she didn't cry. Instead, she took a deep breath of relief, of hope, and of gratitude.
'Today, my daughter gets a second chance at life,' she said softly, almost as if trying to convince herself that this wasn't just another dream.
A few weeks ago, this moment felt impossibly far. The family, Syrian nationals residing in the UAE, had launched an emotional plea on social media to save their daughter who was diagnosed with spinal muscular atrophy (SMA), a rare, serious, and life-threatening genetic disorder and the treatment costs Dh7 million.
But then came a miracle — Sheikh Mohammed bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai, responded to their plea. His office reached out directly to the family and informed them that he would cover the full cost of the gene therapy, giving Yaqeen the lifeline she urgently needed.
'I still can't believe it,' said Ibrahim Kaneker, Yaqeen's father. 'When I got the call, I broke down. I didn't know what to say. I never imagined our cry for help would reach Sheikh Mohammed himself. May God bless him and give him abundantly, he saved our daughter's life.'
'She just stopped moving her legs'
Yaqeen was six months old when her parents noticed something wasn't right. 'She had just started rolling over,' said her mother. 'But then, she stopped. She wasn't kicking her legs anymore. She was quiet. We thought maybe she was tired. But then the days went by... and nothing changed.'
After multiple visits to the doctors and several rounds of testing, the family was given the heartbreaking diagnosis of spinal muscular atrophy, Type 2. It is a genetic condition that affects motor neurons in the spinal cord and brainstem, gradually weakening the muscles that control movement, breathing, and swallowing.
'We were shattered,' said Ibrahim. 'She was so small… how could she already have something so serious? As a father, you want to protect your child. But how do you protect her from something inside her own body?'
Arrival of treatment
Dr Haitham El Bashir, neuro-rehabilitation specialist and head of the gene therapy programme at Al Jalila Children's Hospital, oversaw Yaqeen's treatment. 'She has been diagnosed with SMA, and her symptoms began at around six months,' he said. 'We saw her a few weeks ago, ran all the necessary tests and screening, and confirmed she is eligible for gene therapy.'
The therapy, which costs millions, is a one-time infusion that works by replacing the faulty gene responsible for SMA.
'Today is a big day for her,' said Dr El Bashir. 'The infusion will take about an hour, and then she will stay with us for 24 hours for observation. After that, she will visit us weekly for the next three months so we can monitor her progress. I am very optimistic. She is already showing signs of strength, and with this therapy, she'll have a real chance.'
Yaqeen's mother did not speak much. She didn't need to and her expressions said it all. 'This moment, I will remember forever. When I saw the medicine being brought in… I can't describe the feeling. It was like the weight of the world was lifted from my chest. My daughter's smile tells me everything will be okay.'
A nation that cares
As the family shared their story, there was one emotion that was repeated again and again: gratitude. Gratitude to the UAE, to the hospital staff, to strangers who shared their posts and prayed for them. And most of all, to Sheikh Mohammed.
'He didn't know us. But he helped us like we were his own,' said Ibrahim. My daughter has a chance because we are here, because we were heard.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
11 hours ago
- Zawya
Jinja Hospital officials grilled over Shs1.2 billion payment of water bill
Officials from Jinja Regional Referral Hospital have been tasked to explain circumstances under which they paid Shs1.2 billion to clear water arrears despite being allocated only Shs68 million. The hospital officials led by the Director, Dr. Alfred Yayi appeared before the Public Accounts Committee (Central Government) chaired by the Vice Chairperson, Hon. Gorreth Namugga on Tuesday, 22 July 2025 to respond to queries in the Auditor General's report for the financial year 2023/2024. The legislators were concerned that clearing of the water bill with an amount more than had been allocated amounted to diversion or mischarge of funds. The committee members wondered if the hospital administration had sought authorization from the Ministry of Finance, Planning and Economic Development. 'We actually applaud your creativity in trying to save lives in Jinja City and beyond but we need transparency. Where exactly did you get the money? Which budget votes did you cut? If you used funds from the private wing, say so', Namugga said. According to the Auditor General's report, the hospital has accumulated water arrears of over Shs3.7 billion in a 10-year period. MPs questioned why the hospital had failed to prioritise settling such a substantial domestic arrear. 'So National Water and Sewerage Corporation is that lenient that you have been consuming water for over 10 years without payment? How did you manage that?' Namugga wondered. MPs were also dismayed with the continued under budgeting for utilities by the hospital administrators. 'It seems you are the ones creating these financial problems. You cannot expect government to give you more money when you are under-budgeting. If you need Shs90 million and only budget for Shs30 million, where do you expect the shortfall to come from?' asked Hon. David Karubanga (NRM, Kigorobya County). UPDF Representative, Hon. Victor Nekesa questioned how such a persistent issue continues unresolved even though the hospital submits its budget. Dr. Alfred Yayi requested for more time to provide a comprehensive explanation regarding the source of funds used to clear part of the water arrears after his initial explanation citing a USAID-funded project, was dismissed as insufficient. 'We have not fully addressed the specific issue raised. We request a few hours and will respond by the end of the day,' Dr. Yayi said. He added that while the hospital receives funds from government, it also benefits from a USAID initiative called G2G which reimburses funds upon meeting certain milestones. According to Dr. Yayi, these reimbursements can be used for hospital priorities. Distributed by APO Group on behalf of Parliament of the Republic of Uganda.
Zawya
11 hours ago
- Zawya
Takeda appoints Hernán Porcile as Head of the EAMEA region, continuing its legacy of visionary leadership
From his new base in Dubai, a key international gateway, Hernán will steer Takeda's strategic priorities across diverse, fast-growing EAMEA (Eurasia, the Middle East, and Africa) markets Dubai, United Arab Emirates - Takeda, a global, research and development-driven biopharmaceutical leader, has appointed Hernán Porcile as the new Area Head for its Eurasia, Middle East and Africa (EAMEA) region. Formerly General Manager of Takeda Mexico, Hernán Porcile assumed his new role on July 1, 2025, and is now based in Dubai, United Arab Emirates, from where he will lead the company's strategic developments and accelerate growth across the diverse region. Hernán's appointment comes at a pivotal moment as Takeda intensifies its focus on advancing sustainable, value-based healthcare across the region. Building on the company's strong foundation, Hernán will deepen collaboration with key stakeholders, strengthen local systems, and drive innovation through scientific exchange and partnerships, further reinforcing Takeda's long-term commitment to resilient healthcare infrastructure and fostering a lasting impact. ' The EAMEA region's rapidly evolving healthcare landscape presents tremendous opportunities for Takeda, particularly as key markets in the region pursue bold national visions. As a purpose-driven, patient-centric company, we are proud to contribute to these transformative efforts by advancing access to innovative and high-quality healthcare solutions. The region remains a strategic growth priority for Takeda, as we continue to invest in sustainable healthcare solutions and deepen our presence across key markets, ' said Hernán Porcile, Takeda's newly appointed EAMEA Area Head. Hernán joined Takeda in 2009 as Administration and Finance Director in Argentina and has since held several leadership roles, including serving as Head of Takeda Mexico and Colombia. He has also overseen operations across Latin America, covering the Southern Cone, Andean Region, Mexico, and Central America. Throughout his career, he has led key transformation initiatives and strategic projects, with expertise spanning finance, commercial development, and gastroenterology. Notably, he oversaw the successful launch of three critical therapies aimed at improving outcomes for patients with multiple myeloma, hereditary angioedema, and inflammatory bowel disease. Prior to joining Takeda, he spent over 12 years at Schering-Plough. Hernán also serves as Secretary of the Mexican Association of Pharmaceutical Research Industries (AMIIF), where he leads the Clinical Research Commission. He holds a degree in Public Accounting from the University of Morón in Argentina and an MBA in Strategy from the University of Belgrano. With deep expertise in emerging markets and a strong track record of transformational leadership, Hernán is poised to play a pivotal role in advancing Takeda's mission to deliver better health and a brighter future to patients across the Eurasia, Middle East and Africa area. About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
Zawya
12 hours ago
- Zawya
MoHAP exchanges expertise with visiting delegation as part of the Global Healthcare Leadership Program
UAE, Dubai: The Ministry of Health and Prevention (MoHAP) has received a delegation participating in the Global Healthcare Leadership Program, held in the UAE. The program is organised by the Government Experience Exchange Office of the Ministry of Cabinet Affairs. The visit was attended by His Excellency Dr. Mohammed Salim Al Olama, Undersecretary of MoHAP, alongside Assistant Undersecretaries and senior officials. The delegation's visit aimed to exchange expertise, government administration practices, and share global best practices in healthcare. During the visit, the guests were briefed on MoHAP's key initiatives in digital transformation and innovation within the health sector, as well as the Ministry's efforts to promote preventive care and address health challenges. The visit is part of the UAE's commitment to opening dialogue channels with international health leaders and building healthier societies. It also reflects the UAE's position as a trusted global partner in improving healthcare, driving innovation, and advancing sustainable health security by developing integrated knowledge systems and promoting close collaboration with health leaders and decision-makers across various countries. Comprehensive tour of Centres of Excellence During the visit, the delegation was introduced to the UAE's key achievements in public health, digital transformation of health services, and preventive care. The discussion also touched on how the country is linking its healthcare initiatives to the 2030 Sustainable Development Goals, in line with international efforts to create flexible, equitable, and sustainable health systems. Also addressed were the UAE's strategies to enhance future readiness and tackle global health challenges. The delegation also explored the Ministry's plans for health system governance and were briefed about the coordination between local and federal health authorities. They were provided with an overview of the Ministry's most important strategic and transformational projects and achievements. Additionally, the delegation learnt about the UAE's health regulatory system and the legislative framework that ensures the quality of health services across the country. They also explored the public health system, with a focus on community prevention strategies and proactive responses to epidemics and health emergencies. As part of a field tour, the delegation visited the Ministry's Emergency, Crisis and Disaster Centre, the backbone of the UAE's health preparedness. They also toured the National Centre for Regulating Human Organs and Tissues Transplantation under the Hayat programme, which stands out as a model for ethical and medical leadership. Finally, they visited the Customer Happiness Centre, where they learnt about the UAE's innovative approach to enhancing customer experience and satisfaction in the health sector. Advanced Health Strategies His Excellency Abdulrahman bin Mohamed Al Owais, Minister of Health and Prevention, affirmed that the visit of the delegation, organised in collaboration with the Government Experience Exchange Office at the Ministry of Cabinet Affairs, reflects the international confidence in the UAE's evolving health strategies as well as the global interest in building strategic partnerships with the UAE, especially in digital health and artificial intelligence. 'This is also a testament to the success of the UAE's health system, which is backed by the directives of our wise leadership and national strategies that have positioned the health sector as a central pillar of sustainable development,' the Minister said. Meanwhile, His Excellency Dr. Mohammed Salim Al Olama stated: 'The delegation's visit will further reinforce the UAE's growing role in shaping the future of healthcare worldwide and building international partnerships to exchange knowledge and joint innovation. Leveraging successful experiences, the UAE aims to help create a healthier future for all. 'We will spare no effort to contribute to global health transformation by sharing our expertise in institutional governance and innovation, establishing the UAE as a trusted platform for developing forward-looking health policies.' Al Olama added. Commending UAE's health approach Members of the global delegation commended the UAE's healthcare model, especially its robust digital infrastructure, adaptive legislative framework, and advanced quality systems. They stressed the importance of ongoing collaboration and knowledge-sharing visits, which would play a vital role in creating a globally connected, participatory environment that ensures a healthier future for all societies.
